Pharmacoepidemiology and drug safety
-
Pharmacoepidemiol Drug Saf · Oct 2008
Comparative StudyThe safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
To compare mortality and the incidence of hospitalization for myopathy, rhabdomyolysis, acute renal failure and acute liver injury in patients receiving rosuvastatin and those taking other statins. ⋯ We found no evidence that patients prescribed rosuvastatin were at greater risk of these outcomes than patients prescribed other statins. There was no evidence of increased mortality among patients taking rosuvastatin, even after allowing for age, sex and prior statin use.